Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Laszlo Buga"'
Publikováno v:
Journal of Cardiovascular Medicine. 14:690-697
Heart failure is a complex disease in which a careful clinical examination and the measurement of cardiac function may not always be sufficient for making a correct diagnosis. Measuring plasma levels of natriuretic peptides may assist in this process
Autor:
James Hobkirk, Ashraf Yassin, Andrew L. Clark, Luc Hittinger, Anna Kallvikbacka-Bennett, Jean-Luc Dubois-Randé, Thibaud Damy, Jufen Zhang, Laszlo Buga, John G.F. Cleland, Kevin Goode
Publikováno v:
European Journal of Heart Failure. 13:1340-1348
Aims The prognostic value of signs of congestion in patients suspected of having chronic heart failure (CHF) is unknown. Our objectives were to define their prevalence and specificity in diagnosing CHF and to determine their prognostic value in patie
Autor:
Andrew L. Clark, Alison P. Coletta, Renjith Antony, Pierpaolo Pellicori, Laszlo Buga, John G.F. Cleland, Nick Freemantle
Publikováno v:
European Journal of Heart Failure. 13:460-465
This article provides information and a commentary on key trials relevant to the pathophysiology, prevention, and treatment of heart failure presented at the annual meeting of the American Heart Association held in Chicago in 2010. Unpublished report
Publikováno v:
Journal of the Royal College of Physicians of Edinburgh. 40:229-239
In terms of engineering, clinical understanding and application, device therapy remains in its infancy. In clinical trials, implantable cardiac defibrillators (ICDs) have greatly reduced the rate of sudden death and had a modest impact on mortality i
Publikováno v:
JACC: Cardiovascular Imaging. 3(5):541-549
Section Editor: Thomas H. Marwick, MBBS, PHD cardiac resynchronization therapy (crt) may provide a dramatic improvement of symptom status and outcome in many patients with heart failure. Unfortunately, the use of current selection criteria is associa
Autor:
Laszlo Buga
Publikováno v:
Heart failure reviews. 17(6)
Many factors contribute to the pathophysiology and progression of heart failure (HF), offering the potential for many synergistic therapeutic approaches to its management. For patients, who have systolic HF, prolonged QRS and receiving guideline-indi
Autor:
Laszlo Buga, John G.F. Cleland
Publikováno v:
Heart failure reviews. 17(6)
The introduction of cardiac resynchronization therapy (CRT) has changed the modern treatment of heart failure [1–4] and become a fruitful new area of research, especially imaging research [5, 6] and the development of ‘‘smarter’’ pacemaker
Publikováno v:
European journal of heart failure. 12(6)
This article provides information and a commentary on trials relevant to the pathophysiology, prevention and treatment of heart failure presented at the annual meeting of the American College of Cardiology held in March 2010. Unpublished reports shou
Publikováno v:
Kleijn, S A & van der Veldt, A A M 2010, ' An Entirely Subcutaneous Implantable Cardioverter-Defibrillator ', New England Journal of Medicine, vol. 363, no. 16, pp. 1577-1577 . https://doi.org/10.1056/nejmc1008499
New England Journal of Medicine, 363(16), 1577-1577. Massachussetts Medical Society
New England Journal of Medicine, 363(16), 1577-1577. Massachussetts Medical Society
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b93fe7f486a26a1159eb0108bc910830
https://research.vumc.nl/en/publications/c06543f6-779c-4f3b-ac98-55c2a496c0b5
https://research.vumc.nl/en/publications/c06543f6-779c-4f3b-ac98-55c2a496c0b5
Autor:
John G.F. Cleland, Ashraf Yassin, Azam Torabi, Laszlo Buga, Andrew L. Clark, Alison P. Coletta
Publikováno v:
European journal of heart failure. 11(12)
This article provides information and a commentary on trials relevant to the pathophysiology, prevention, and treatment of heart failure presented at the annual meeting of the European Society of Cardiology held in Barcelona in 2009. The AAA study do